Technical Support
(877) SEPAX-US
, press 3
TechSupport@sepax-tech.com
Contact Us
|
Sign In
|
Home
About Sepax
Company Profile
Technology
Employment
Contact Us
Products
By Separation Mode
By Brand
By Sample Based Application
Size Exclusion
Ion Exchange
Hydrophobic Interaction
Ion Exclusion
Sub-2 UHPLC
Purification
Reversed Phase
Mixed-mode Phase
HILIC
View All
SEC-MALS
Unix
/
Unix-C
Zenix
/
Zenix-C
SRT
/
SRT-C
SRT-10 / SRT-10C
Proteomix HIC
/
IEX
Antibodix
Carbomix
Proteomix RP
View All
ADC
Antibody
Biosimilar
Carbohydrate
Cell Lysate
DNA/RNA
Fusion Protein
Glycan
Glycoprotein
Heparin
Insulin
Membrane Protein
Organic Acid
PEG/PEGylated Protein
Peptide
Polymer
Protein
Vaccine/VLP
Others
Services
Analytical Chrom.
Prep Purification
Custom Resin
Surface Coating
Affinity Services
Application
Resources
Order
How May We Help You?
X
Submit
How May We Help You?
X
Name
Email
Phone
State
Country
How May We Help You?
X
Your question has been submitted.
We will respond back to you shortly.
Ask Another
How May We Help You?
X
Please fill out all required fields.
Try Again
Representative Literature References
Click a row to open its literature reference.
Product
';
All
Bio C-18
Bio-C4
Bio-C8
BioMix SEC-300
BR-C18
Carbomix H-NP10
GP-C18
GP-C8
HP-Diol
Nanofilm SEC-150
Nanofilm SEC-250
Nanofilm SEC-500
Polar MC-SP, 30 μm
Polar-Imidazole
Proteomix HIC butyl-NP5
Proteomix HIC Ethyl NP5
Proteomix HIC Phenyl-NP5
Proteomix RP-1000
Proteomix SAX NP3
Proteomix SAX-NP (4.6 mm × 150 mm, 5 μm; Sepax)
Proteomix SAX-NP3
Proteomix SAX-NP5
Proteomix SCX NP5
Proteomix SCX-NP10, Antibodix WCX-NP5
Proteomix SCX-NP3
Proteomix SCX-NP5
Proteomix SCX-NP5, PEEK
Proteomix WAX-NP5
SEC
SRT 2000 4.6X30
SRT SEC 300, 500, and 1000
SRT SEC-100
SRT SEC-1000
SRT SEC-1000 PEEK
SRT SEC-150
SRT SEC-2000
SRT SEC-300
SRT SEC-300, SRT SEC-500, SRT SEC-1000
SRT SEC-500
SRT-10 300
SRT-10 SEC-300
SRT-1000
SRT-10C SEC-100
SRT-10C SEC-300
SRT-150
SRT-2000
SRT-C SEC-1000
SRT-C SEC-1000, SRT-C SEC-2000
SRT-C SEC-150
SRT-C SEC-300
SRT-C SEC-500
Unix-C SEC-300
Zenix 300
Zenix SEC 300
Zenix SEC-100
Zenix SEC-150
Zenix SEC-300
Zenix SEC-300 & Proteomix HIC butyl-NP5
Zenix SEC-300, 3um, 300 A 7.8 x 300 mm
Zenix SEC-300, 4.6 x 300mm
Zenix SEC-80
Zenix-C
Zenix-C and Proteomix HIC butyl-NP5
Zenix-C SEC-150
Zenix-C SEC-300
Zenix-C SEC-80
PN
';
All
101185-4615
102185-4625
106185-4625
110043-4625, 110043-10025
213300-4615
213300-4630
213300-4630, 431NP5-4603
213300-7830
213300LS-7830
214300-7830
215150
215150-7825
215150-7830
215300-4625
215300-7815
215300-7815, 215500-7815, 215950-7815
215300-7830
215500-4630
215500-7830, 215500-7805, 215300-7830, 215300-7805, 215950-7830, 215950-7805
215950-30030
215950-4630
215950-7815
215950-7830
215950-7830, 102002-COUPLER, 215950-7805
215950P-4630
215980-10030
215980P-4630
225300-21230
225300-21230, 225300-10030
231300-4615
231300-4615, 231300-4602
233150-7830
233300-10030
233300-4630
233300-7830
233300-7830 & 431NP5-4603
235150
235300-4625
235300-4630
235300-7830
235300-7830,235300-7805
235500-21230
235500-4615, 102002-COUPLER, 235500-4605
235980-7830,102002-COUPLER, 235950-7830
235980-7830; 235950-7830
239100-10030
239300-21230
239300-30030
283030
401NP10-4625, 401NP10-10025, 401NP10-21225, 401NP10-10005, 602NP5-4625
401NP3-4615
401NP5-4610
401NP5P-4625
403NP3-7815
403NP5-4615
403NP5-4625
404NP5-4605
431NP5-4603
431NP5-4605
431NP5-4610
431NP5-4625
432NP5-7810
433NP5-4610
465950-2105
465950-2110
465950-2115
465950-4610
465950-4615
N/A
Not Mentioned
Separation Mode
';
All
HIC
IEX
RP
SEC
OTHER
Broad Sample Type
';
All
2-AA Labeled Glycan Standards, Others
AAV
ADC
ADC, Fusion Protein
Antibody
Antibody, IgE
Bispecific Antibody
BsAbs
BsMAb
Carbohydrate
Cell Lysate
Dendritic Polymer, Polymeric Nanomedicines
DNA
DNA/RNA
DNA/RNA/OLIGO
Enzymes
Factor VIII Fc Fusion Protein
Fusion Protein
GPCR, Membrane Protein
Insulin
Liposome
Membrane Protein
Membrane Protein, Rhodopsin
Metal
Nanoparticle
Oligodeoxynucleotides
Oligonucleotides
Other Proteins
Others
Others, Protein
Others-nanotube
PEG/PEGylated Protein
Peptide
Polymer
Polymer of Cefmetazole
Polymeric Amines and Ampholytes
Polymeric Substances
Polyurethane/Epoxy Hybrid Polymers
Protein
Protein, DNA/RNA
Protein-Kinase
Protein-Peptide Complex
Saccharides
Small Molecule
Urine
Vaccine
VLP/Virus/Vaccine
Wastewater
Specific Sample
';
All
(His)-tagged hFZD7 CRD
5.8S and 5S rRNA
AA and EGF
AAV
AAV5
AAV8 and AAV9
AAV9
AAV9, AAV2
ABF710
ACKR3
ADC
ALK1-Fc fusion protein
ant-TNF-ang2 bsMab
anthrax vaccines pp-dPA83
Anti-HER2 Immune-Stimulating ADC
Anti-tumor necrosis factor (TNF), IL-17A, BsMAb
Antibody
antisense oligonucleotide (ASO)
BcRsaM protein
bispecific antibody
BsAbs
BsMAb
BsMAb, IgG1, knob-into-hole
CAS-9
Cas-9 and gRNA
CdiIo2 MC58-1, an orphan CDI immunity protein from N. meningitidis MC58.
Cetuximab
chemokine receptor (45kd), viral chemokine, disulfide trapped complexes (55kd), N terminal-Cys CXCR4-Cys: Chemokine Receptor vMIP-II-Cys: viral chemokine
Chemokine, Herpesviridae (herpesvirus), 7TM receptor, Baculovirus infected Spodoptera frugiperda (Sf9) insect cells
chemokines, CXCL12, G protein
circ-arRNA
circRNA
circular mRNA
Clarified cell culture supernatant
Complex with mAb
CPf1 and CAS-9 analogs
CRISPR-Cpf1 (Cas12a)
cRNA - Engineered
Cysteine ADC based on IgG1
cytokinin-activating BP1253
desialylated protein
Epitopes from overlapping 10mer regions
Factor VIII Fc Fusion protein
FcgRIIA and FcgRIIB
FcγR
Generalized Modules for Membrane Antigens (GMMA), which are are outer membrane vesicles naturally released by Gram-negative bacteria. GMMA are small outer membrane vesicles-like blebs (40-200 nm diameter) spontaneously released by Gram-negative bacteria ...
Glycan-based Site Specific ADC
GPCR
HBcAg
hepatitis B core antigen (HBcAg) VLP as carrier for therapeutic human papillomavirus (HPV) vaccines, expressed efficiently in E. coli cells, recombinant vaccine protein HBcAg-E749–57 was assembled into VLPs similar to the carrier protein HBcAg, whic…
Hepatitis B Virus
HEX Antibody carrier or HEX-antibody complexes
Hexavalent Chromium Cr(VI)
HIV Env Trimer
HIV Trimer
HIV-1 Env Antibody
HPV16 E7-specific vaccine
Human diacylglycerol O-acyltransferase-1 (hDGAT1), from cell memebranes.
Human IgG1 Mab
Human interleukin 11α receptor
IgG
IgG2 isoforms
IgG4
infliximab
influenza vaccine candidate H1ssF
Insulin Analogs
IP268 and Dulaglutide (IP118)
α4β2–Fab complexes
lentil legumin-like protein
Lysozyme-like Protein, STM3605 protein
mAb
mAbs
mAbs - SARS-CoV-2
mAbs of 12 varieties
mAbs with Vκ or Vλ variability
Membrane Protein
methylated peptides
MMAE-trastuzumab ADC
Monoclonal Antibodies
Mosaic Influenza
mRNA-LNP (Lipid Nanoparticle)
N/A
native IgG1 and pI engineered
Oligosaccharides
OmpA C-terminal domains
Oxy Enzymes
p-rhASM/G-S
paclitaxel (PTX)
partial heavy chain/light chain assemblies of various regions to create chimeric antibodies.
Pegunigalsidase
PEGylated Lipsome Peptide
PEGylated Mesoporous Silica Nanoparticles
Pfs25-CP VLP
Pfs25-CP VLP.
Polymerase
Polysaccharide Vaccine
Protein
protein and small molecules
protein candidate vaccine
Protein Tyrosine Sulfation
protein-metabolite complexes
Protein-peptide complex
Recombinant T cell receptors (TCR)/TCR fragments
rFVIII
RNA
RV3 Fusion (F) Protein
SARS-COV-2 Spike Protein
scFv-IgG bispecific
sdAbs
SEC c2G4-BDS; CMB-BDS-1410-001
Sildenafil and Carbamazepine
Site Specific ADC
Site-specific ADC
Small Molecuele Conjugation
STS-1 enzyme
Synthetic nanobodies
Thienoduocarmycin-trastuzumab ADC
TIR and cGAS inhibitors
Trastuzumab-derived variants containing pAMF were conjugated to MMAF, MMAE, and maytansinoid
vaccine protein
Various VAR2CSA domains
VLP
xenopolymerase for RT-PCR
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
Next
View All
Year
Product
PN
Sep. Mode
Broad Sample Category
Specific Sample
Title
2025
SRT SEC-150
215150-7830
SEC
Protein
TIR and cGAS inhibitors
Structure-guided discovery of viral proteins that inhibit host immunity
SRT SEC-150
215150-7830
Protein
TIR and cGAS inhibitors
2025
SRT-C SEC-300
235300-7830,235300-7805
SEC
VLP/Virus/Vaccine
Epitopes from overlapping 10mer regions
A broad spectrum Shigella vaccine based on VirG53-353 multiepitope region produced in a cell-free system
SRT-C SEC-300
235300-7830,235300-7805
VLP/Virus/Vaccine
Epitopes from overlapping 10mer regions
2025
SRT SEC-1000
215950-7830
SEC
VLP/Virus/Vaccine
AAV5
Formulation development and feasibility of AAV5 as a lyophilized drug product
SRT SEC-1000
215950-7830
VLP/Virus/Vaccine
AAV5
2025
Proteomix HIC Phenyl-NP5
433NP5-4610
HIC
Antibody
Small Molecuele Conjugation
Process Analytical Technology for Real-Time Monitoring of Pharmaceutical Bioconjugation Reactions
Proteomix HIC Phenyl-NP5
433NP5-4610
Antibody
Small Molecuele Conjugation
2024
Proteomix HIC Butyl-NP5
431NP5-4610
HIC
Antibody
Protein Tyrosine Sulfation
Structure-function Relationship Study for Sulfated Protein Therapeutics Using Hydrophobic Interaction Chromatography and Mass Spectrometry
Proteomix HIC Butyl-NP5
431NP5-4610
Antibody
Protein Tyrosine Sulfation
2024
Unix-C SEC-300
231300-4615, 231300-4602
SEC
Fusion Protein
RV3 Fusion (F) Protein
Universal Paramyxovirus Vaccine Design by Stabilizing Regions Involved in Structural Transformation of the Fusion Protein
Unix-C SEC-300
231300-4615, 231300-4602
Fusion Protein
RV3 Fusion (F) Protein
2024
Proteomix HIC Butyl-NP5
431NP5-4625
HIC
BsMAb
Monoclonal Antibodies
In-Depth Characterization for Methionine Oxidization in Complementary Domain Region by Hydrophobic Interaction Chromatography
Proteomix HIC Butyl-NP5
431NP5-4625
BsMAb
Monoclonal Antibodies
2024
Proteomix WAX-NP5
404NP5-4605
IEX
Metal
Hexavalent Chromium Cr(VI)
Development of a Fast Method Using Inductively Coupled Plasma Mass Spectrometry Coupled with High-Performance Liquid Chromatography and Exploration of the Reduction Mechanism of Cr(VI) in Foods
Proteomix WAX-NP5
404NP5-4605
Metal
Hexavalent Chromium Cr(VI)
2024
Proteomix SCX-NP3
401NP3-4615
IEX
Antibody
Monoclonal Antibodies
Online Multimethod Platform for Comprehensive Characterization of Monoclonal Antibodies in Cell Culture Fluid a Single Sample Injection - Intact Protein Workflow
Proteomix SCX-NP3
401NP3-4615
Antibody
Monoclonal Antibodies
2024
SRT SEC-1000
215950-7815
SEC
Nanoparticle
Mosaic Influenza
Mosaic Quadrivalent Influenza Vaccine Single Nanoparticle Characterization
SRT SEC-1000
215950-7815
Nanoparticle
Mosaic Influenza
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
Next
View All
© 2025 Sepax Technologies, Inc. All Rights Reserved.
Products
|
Privacy Policy
|
Career
|
Contact Us
